Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Faria, V
We are committed to the strict standards of Canadas Personal Information Protection and Electronic Documents Act
"For people with type 2 diabetes who are at the point in their treatment journey where they would progress to an injectable therapy, these positive results emphasize tirzepatide's potential to deliver a meaningful impact in lowering their A1C and weight," said Bernhard Ludvik, M.D., Associate Professor of Medicine, Landstrasse Clinic, Vienna, and Principal Investigator of SURPASS-3
This occurred in 4.9 - 5.7% of people using 5 - 15 mg doses compared to 0.9% of people who were given a placebo
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 24.81
US$ 25.69
US$ 23.58
